 |
|
Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission
Tsz Wai Catherine Wong, Man Yee Shirley Wong, Wai Man Betty But
Ann Pediatr Endocrinol Metab. 2021;26(2):118-125. Published online 2021 Jun 30 DOI: https://doi.org/10.6065/apem.2040202.101
|
|
Citations to this article as recorded by
 Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study
Laure Boutsen, Elise Costenoble, Olivier Pollé, Kezban Erdem, Céline Bugli, Philippe A. Lysy
Therapeutic Advances in Endocrinology and Metabolism.2023; 14: 204201882211455. CrossRef Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Laia Gomez-Muñoz, David Perna-Barrull, Josep M. Caroz-Armayones, Marta Murillo, Silvia Rodriguez-Fernandez, Aina Valls, Federico Vazquez, Jacobo Perez, Raquel Corripio, Luis Castaño, Joan Bel, Marta Vives-Pi
Frontiers in Immunology.2022;[Epub] CrossRef Postinitial remission in children with type 1 diabetes mellitus
Kristína Podoláková, Denisa Lobotková, Emília Jančová, Ľudmila Podracká, Ľubomír Barák, Juraj Staník
Česko-slovenská pediatrie.2022; 77(2): 72. CrossRef Postinitial remission in children with type 1 diabetes mellitus
Kristína Podoláková, Denisa Lobotková, Emília Jančová, Ľudmila Podracká, Ľubomír Barák, Juraj Staník
Česko-slovenská pediatrie.2022; 77(2): 72. CrossRef What Is a Honeymoon in Type 1, Can It Go into Remission?
Anuradha Viswanathan, Jamie R. Wood, Betul Hatipoglu
Endocrinology and Metabolism Clinics of North America.2022;[Epub] CrossRef
|